Cytarabine/Daunorubicin Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of cytarabine and daunorubicin that can be used for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN), acute myeloid leukemia (AML), and acute promyelocytic leukemia (APL).

**Synonyms:** - 5 and 2 Consolidation Regimen - 5-2 Consolidation Regimen - 7 and 3 Induction Regimen - 7-3 Induction Regimen - AraC-Daunorubicin Regimen - Cytarabine and Daunorubicin - Cytarabine-Daunomycin Regimen - Cytarabine-Daunorubicin - Cytarabine-Daunorubicin Regimen - Cytarabine/Daunorubicin - HD Ara-C/Daunorubicin - HD Cytarabine/Daunorubicin - High-dose Cytarabine-Daunorubicin